BiomX (PHGE) Short term Debt (2018 - 2023)
BiomX (PHGE) posted Short term Debt of $5.8 million for Q4 2023, up 815.35% sequentially from $632000.0 in Q3 2023, and up 35.1% YoY from $4.3 million in Q4 2022.
BiomX (PHGE) Short term Debt (2018 - 2023) Analysis & Trends
BiomX has reported Short term Debt for 6 years, with the latest figure at $5.8 million in Q4 2023.
- Quarterly Short term Debt rose 35.1% year-over-year to $5.8 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $5.8 million (up 35.1% YoY) and the FY2023 annual result came in at $5.8 million, up 35.1% from the prior year.
- Short term Debt grew to $5.8 million in Q4 2023 per PHGE's latest filing, from $632000.0 in the prior quarter.
- Over five years, Short term Debt peaked at $5.8 million in Q4 2023 and troughed at $361000.0 in Q1 2020.
- A 5-year average of $1.2 million and a median of $708000.0 in 2022 frame the typical range for Short term Debt.
- The sharpest annual moves came in 2019 and 2023: Short term Debt soared 650.0% in 2019, then declined 15.32% in 2023.
- Over 5 years, Short term Debt stood at $375000.0 in 2019, then surged by 130.13% to $863000.0 in 2020, then decreased by 5.1% to $819000.0 in 2021, then jumped by 422.83% to $4.3 million in 2022, then surged by 35.1% to $5.8 million in 2023.
- According to Business Quant data, Short term Debt over the past three periods registered $5.8 million, $632000.0, and $654000.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | BiomX | 361,408.40 | -806,591.60 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 5.79 Mn |
| Sep 30, 2023 | 632,000.00 |
| Jun 30, 2023 | 654,000.00 |
| Mar 31, 2023 | 669,000.00 |
| Dec 31, 2022 | 4.28 Mn |
| Sep 30, 2022 | 687,000.00 |
| Jun 30, 2022 | 708,000.00 |
| Mar 31, 2022 | 790,000.00 |
| Dec 31, 2021 | 819,000.00 |
| Sep 30, 2021 | 799,000.00 |
| Jun 30, 2021 | 791,000.00 |
| Mar 31, 2021 | 763,000.00 |
| Dec 31, 2020 | 863,000.00 |
| Sep 30, 2020 | 594,000.00 |
| Jun 30, 2020 | 369,000.00 |
| Mar 31, 2020 | 361,000.00 |
| Dec 31, 2019 | 375,000.00 |
| Dec 31, 2018 | 50,000.00 |